UMDF

Mitochondrial Disease

Conference Location

Support/Exhibit

   

 

Scientific Session Schedule

Mitochondrial Medicine 2013 Scientific Program
Mitochondrial Therapeutics - From Bench to Bedside

Newport Beach Marriott Hotel & Spa - Newport Beach, California, USA

Click Here for Printable Copy of Program

On-Line Registration is now open - Click Here!

Day 1: June 12 (Wednesday)

 

Morning Platform Session (1) – Platform Title: Mitochondrial Disorders in the 21stCentury – Is treatment possible?

8:00 a.m.

Welcome and Treatment of Mitochondrial Disease

  Greg Enns, MB, ChB, Course Chair

8:45 a.m.

Topic Title: NCATS - Repurposing drugs for rare diseases
   
James Inglese, PhD, NCATS, NIH, Bethesda, MD

 

9:15 a.m.

Topic Title: NAMDC – Registries and the Future of Mitochondrial Trials
   
Speaker Name:Russ Saneto, DO, PhD, Seattle Children’s, WA
   and Salvatore DiMauro, MD, Columbia University, NY

9:45 a.m.

Break

10:15 a.m.

Abstract Presentations (5)

11:30 a.m.

Topic Title: Mitochondrial Disease Sequence Data Resource (MSeqDR) Consortium: Update
and Prototype Develop Project Overview
Speaker Name: Marni Falk, MD, Children's Hospital of Philadelphia, PA

12:00 p.m.

Lunch


Afternoon Platform Session (2) – Platform Title: The Science Behind Clinical Management

2:00 p.m.

Topic Title: To Appreciate the Interactions of Anesthetics and Perioperative

  Medications with Mitochondrial Disease
   
Speaker Name:Phil Morgan, MD, Seattle Children’s, WA

2:30 p.m.

Topic Title: It’s not your Mother’s Ribosome Anymore
   
Speaker Name:Thomas O’Brien, PhD, University of Florida, FL

3:00 p.m.

Topic Title: Drugs – the Good, the Bad and the Ugly
   
Speaker Name:Bruce Cohen, MD, Akron Children’s, Akron, OH

3:30 p.m.

Abstract Presentations (3)

4:15 p.m.  

Break & Poster Sessions(non cme) - Even Numbers Stay at Posters

6:30 p.m.

Adjourn

 

A 5-minute question and answer period is included in each of the speaker's allotted time.

 

Day 2: June 13 (Thursday)

Morning Platform Session (3) – Platform Title: Mitochondrial Imaging

8:00 a.m.

Topic Title: Regulation of Mitochondrial Dynamics
   
Speaker Name:David Chan, MD, PhD, California Institute of Technology, Pasadena, CA

8:30 a.m.

Topic Title: Assessment of In Vivo Muscle Mitochondrial Metabolism by Magnetic Resonance Spectroscopy
   
Speaker Name:Jeanine Prompers, PhD, Eindhoven University of Technology, The Netherlands

9:00 a.m.

Topic Title: Magnetic Resonance Spectroscopy Observation of Brain and Muscle
   Mitochondrial Function
   
Speaker Name:Juan M. Pascual, MD, PhD, University of Texas Southwestern Medical

    Center, Dallas, TX

9:30 a.m.

Topic Title: HMPAO-SPECT – Redox neuroimaging
   
Speaker Name:Francis Blankenberg, MD, Stanford Cancer Institute, Palo Alto, CA

10:00 a.m.

Break

10:30 a.m.

Abstract Presentations (6)

12:00 p.m.

Lunch


Afternoon Platform Session (4) – Platform Title: Next Gen Reporters of Cellular Metabolism

2:00 p.m.

Topic Title: Mitoplasticity: Mitochondrial Adaption Biology – Implications for Therapies in Cancer and Neurodegenerative Diseases.
   
Speaker Name:Rodrigue Rossigol, PhD, Université Victor Segalen-Bordeaux 2, France

2:30 p.m.

Topic Title: Optical sensors for In Vivo Biochemistry
   
Speaker Name:Wolf B. Frommer, PhD, Carnegie Institute of Science and Stanford School

    Of Medicine, Palo Alto, CA

3:00 p.m.

Abstract Presentations(5)

4:30 p.m.

Break and Posters (non cme) - Odd Numbers Stay at Posters

Reception and Cash Bar

6:30 p.m.

Adjourn

4:30-7:30p

Clinical Directors Workshop – Mitochondrial Medicine Society Moderating

Tentative Topics and Speakers:

-Natural History Studies and CDEs for Outcome Measures
   Petra Kaufmann, MD, MSc, NINDS

-Towards the Harmonization of Outcome Measures in Children with
   Mitochondrial Disorders, Saskia Koene, MD, AGIKO Paediatrics

-Planning Clinical Trials, Choosing Outcome Measures and More
  Greg Enns, MB, ChB, Stanford University Medical Center

-UMDF Clinical Research Committee Update, Richard Haas, MB, BChir, UCSD

-Presentation of the MMS Survey Data, Sumit Parikh, MD, President, MMS

-Additional Discussion and Plans for the 2014 Meeting

 

A 5-minute question and answer period is included in each of the speaker's allotted time.

 

Day 3: June 14 (Friday)

 

Morning Platform Session (5) – Platform Title: Animal Models and Translational Research

8:00 a.m.

Topic Title: Of Mice and Mitochondria
   
Speaker Name:Douglas Wallace, PhD, Children’s Hospital of Philadelphia, PA

8:30 a.m.

Topic Title: Strategies for Determining Pathogenicity of POLG1 Variants
   
Speaker Name: Laurie Kaguni, PhD, Michigan State University, MI

9:00 a.m.

Topic Title: Mitochondrial Biogenesis/Creatine
   
Speaker Name: Carlos Moraes, PhD, Miami University, FL

9:30 a.m.

Abstract Presentations: (2)   

10:00 a.m.

Break

10:30 a.m.

Topic Title: Targeting drug therapy to cell signaling alterations
   
Speaker Name:Marni Falk, MD, Children’s Hospital of Philadelphia, PA

11:00 a.m.

Abstract Presentations (5)

12:15 p.m.

Lunch


Afternoon Platform Session (6) – Platform Title: Translational Mitochondrial Medicine

2:00 p.m.

Topic Title: Coenzyme Q10 as a Therapy for Mitochondrial Disease

   Speaker Name:Iain Hargreaves, PhD, National Hospital, UK

2:30 p.m.

Topic Title: The Role of Arginine and Citrulline Supplementation in MELAS Syndrome

   Speaker Name:Fernando Scaglia, MD, FACMG, Baylor College of Medicine, Houston, TX

3:00 p.m.

Topic Title: Diseases of Mitochondrial Translation
   
Speaker Name:Rita Horvath, MD, PhD, Newcastle University, UK

3:30 p.m.

Break

3:45 p.m.

Topic Title: Mitochondrial Function Ex Vivo – the Use of Fibroblasts
   
Speaker Name:Ann Saada (Reisch), PhD, Hadassah-Hebrew University Medical
    Center, Jerusalem, Israel

4:15 p.m.

UMDF 2013 Funded Projects (abstracts)

5:30 p.m.

Adjourn

6:00 p.m.

Reception

7:00 p.m.

Friday Night Banquet and Awards Ceremony

 

A 5-minute question and answer period is included in each of the speaker's allotted time.

 

Day 4: June 15 (Saturday)

Morning Platform Session (7) – Platform Title: Bringing New Therapies to Market

8:00 a.m.

Topic Title: The View from the FDA

   Speaker: LaRee A. Tracy, MA, PhD, CDR, USPHS, San Diego, CA

8:30 a.m.

Topic Title: Using Dietary Supplements as Treatments for Mitochondrial 
   Disorders: Clinical and Research Challenges
   
Speaker Name: Paul Coates, PhD, Office of Dietary Supplements, NIH

9:00 a.m.

Topic Title: Bendavia: a Novel Therapy for Restoring Mitochondrial Function in Disease
   Speaker Name:Travis Wilson, CEO, Stealth Peptides Inc.

9:15 a.m.

Topic Title: Epicatechin Derivatives
   
Speaker Name:George F. Schreiner, MD, PhD, Cardero Therapeutics, San
   Francisco, CA

9:30 a.m.

Topic Title: Update on Clinical Development of EPI-743

    Speaker Name:Matthew Klein, MD, MS, FACS (Edison)

9:45 a.m.

Topic Title: Successes in the Orphan Disease Field
   
Speaker Name:Stuart J. Swiedler, MD, PhD (BioMarin)    

10:00 a.m.

Break - pick up box lunches and return to seating for panel


10:30 am to 1:30 pm

Panel Discussion -  <<Convene during lunch >>


1:30 p.m.

Adjournment

 A 5-minute question and answer period is included in each of the speaker's allotted time.

   

8085 Saltsburg Road, Suite 201 | Pittsburgh, PA 15239 | Toll-Free 1-888-317-UMDF | P 412.793.8077 | F 412.793.6477 | info@umdf.org | www.umdf.org